[Correction of the secondary effects of so-called neuroleptic drugs].
D000661:Amphetamine / Q000627:therapeutic use*; D000662:Amphetamines; D014150:Antipsychotic Agents; D002746:Chlorpromazine / Q000627:therapeutic use*; D001523:Mental Disorders / Q000628:therapy*; D011612:Psychosurgery; D011613:Psychotherapy; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D000662:Amphetamines; D014150:Antipsychotic Agents; D046948:Secologanin Tryptamine Alkaloids; D014282:Trihexyphenidyl; D000661:Amphetamine; D002746:Chlorpromazine
AMPHETAMINE/therapeutic use; CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use; TRIHEXYPHENIDYL/therapeutic use
La correction des effects secondaires des médications dites neuroleptiques.